Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased bacterial resistance: PROTEKT US--an update.

Michael J Rybak1

  • 1Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI 48201-2417, USA. m.rybak@wayne.edu

The Annals of Pharmacotherapy
|July 1, 2004
PubMed
Summary

Antimicrobial resistance is rising in community-acquired respiratory tract infections (CARTIs). The PROTEKT study shows telithromycin remains effective against resistant Streptococcus pneumoniae, unlike other common antibiotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of colistin minimum inhibitory concentration on clinical failure and mortality: insights from the OVERCOME trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infections.

BMC infectious diseases·2026
Same author

Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

Antimicrobial agents and chemotherapy·2026
Same author

Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving Enterobacterales.

Microbiology spectrum·2026
Same author

Optimizing discharge antibiotic prescribing: A multicenter evaluation of pharmacist-led interventions in community hospitals.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis.

BMC infectious diseases·2025

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Community-acquired respiratory tract infections (CARTIs) cause significant morbidity and mortality in the US.
  • Increasing antimicrobial resistance in pathogens like Streptococcus pneumoniae complicates treatment.
  • There is a critical need for surveillance and new antimicrobial agents.

Purpose of the Study:

  • To present antimicrobial resistance surveillance data from the US component of the PROTEKT study.
  • To compare the activity of telithromycin against other agents.
  • To track resistance patterns in common respiratory pathogens.

Main Methods:

  • The Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin (PROTEKT) US study was initiated in 2000.

Related Experiment Videos

  • Longitudinal surveillance data from the 2000-2001 respiratory infection season were analyzed.
  • Resistance patterns were assessed at national, regional, and local levels.

    • Main Results:

    • The study confirmed increasing resistance of Streptococcus pneumoniae to beta-lactams and macrolides.
    • Emergence of fluoroquinolone resistance in US pathogens was observed.
    • Telithromycin demonstrated high activity against Streptococcus pneumoniae, including resistant strains.

    Conclusions:

    • Antimicrobial resistance is a growing concern for CARTIs in the US.
    • Telithromycin shows significant promise as an effective agent against resistant Streptococcus pneumoniae.
    • Ongoing surveillance is crucial for guiding antimicrobial therapy.